Patient: SAMPLEPATIENT

DOB: Sex: MRN:

© Genova Diagnostics · A. L. Peace-Brewer, PhD, D(ABMLI), Lab Director · CLIA Lic. #34D0655571 · Medicare Lic. #34-8475

Omega 3 Fatty Acids Omega 6 Fatty Acids

>= 0.09 wt %0.14

>= 0.16 wt %0.86

>= 1.14 wt %2.53

>= 2.1 wt %7.3

>= 3.8 10.9

10.5-16.9 wt %9.6

0.03-0.13 wt %0.09

>= 1.19 wt %1.10

15-21 wt %22

1.50-4.20 wt %3.24

<= 0.26 wt %0.18

30.5-39.736.4

Cardiovascular Risk

Saturated Fatty Acids

Delta - 6 Desaturase Activity

Monounsaturated Fats

Omega 9 Fatty Acids

10-13 wt %11

2.1-3.5 wt %3.2

13.3-16.614.2 <= 0.64 wt %0.24

<= 1.13 wt %0.65

<= 0.59 wt %0.27

39.8-43.637.4

18-23 wt %17

14-17 wt %16

0.22-0.37 wt %0.27

0.07-0.15 wt %0.11

0.22-0.35 wt %0.23

0.92-1.68 wt %0.98

0.12-0.18 wt %0.22

2.1-3.8 wt %2.9

6.0-12.38.7

3.4-10.73.4

12-12526

>= 4.0 8.2

GDX-4-181

ID: Patie t: nt: SAMPLE PATIENT Page 2

© Genova Diagnostics · A. L. Peace-Brewer, PhD, D(ABMLI), Lab Director · CLIA Lic. #34D0655571 · Medicare Lic. #34-8475

Essential Fatty Acid Metabolism

0.14 9.6

0.09

1.10

22

3.24

0.86

2.53

7.3

This test was developed and its performance characteristics determined by Genova Diagnostics, Inc. It has not been cleared or approved by the U.S. Food and Drug

Administration.